DIAPH2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.106400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.536800E-01
Normal-vs-Stage2
2.533000E-01
Normal-vs-Stage3
9.345400E-01
Normal-vs-Stage4
4.899700E-02
Stage1-vs-Stage2
3.492400E-01
Stage1-vs-Stage3
4.572600E-01
Stage1-vs-Stage4
2.834100E-02
Stage2-vs-Stage3
2.084400E-01
Stage2-vs-Stage4
1.417600E-01
Stage3-vs-Stage4
2.819700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.420600E-01
Normal-vs-AfricanAmerican
1.515210E-01
Normal-vs-Asian
3.640200E-01
Caucasian-vs-AfricanAmerican
6.131600E-01
Caucasian-vs-Asian
9.352200E-01
AfricanAmerican-vs-Asian
7.022000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.773800E-01
Normal-vs-Female
3.688800E-01
Male-vs-Female
1.025230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.277800E-01
Normal-vs-Age(41-60Yrs)
1.800650E-01
Normal-vs-Age(61-80Yrs)
4.039600E-01
Normal-vs-Age(81-100Yrs)
3.081600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.968200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.410000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.497600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.563800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.241200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.503600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.570000E-01
Normal-vs-Daily Drinker
5.961000E-01
Normal-vs-Weekly Drinker
4.426000E-01
Normal-vs-Occasional Drinker
3.591600E-01
Normal-vs-Social Drinker
3.659600E-01
Non Drinker-vs-Daily Drinker
8.539000E-01
Non Drinker-vs-Weekly Drinker
8.538800E-01
Non Drinker-vs-Occasional Drinker
6.644800E-01
Non Drinker-vs-Social Drinker
8.745400E-01
Daily Drinker-vs-Weekly Drinker
9.781200E-01
Daily Drinker-vs-Occasional Drinker
6.397800E-01
Daily Drinker-vs-Social Drinker
8.073400E-01
Weekly Drinker-vs-Occasional Drinker
6.363200E-01
Weekly Drinker-vs-Social Drinker
8.030600E-01
Occasional Drinker-vs-Social Drinker
8.102400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.098000E-01
Normal-vs-Grade 2
3.218300E-02
Normal-vs-Grade 3
7.921600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.581100E-03
Grade 1-vs-Grade 3
2.316300E-02
Grade 1-vs-Grade 4
2.098000E-01
Grade 2-vs-Grade 3
8.110200E-01
Grade 2-vs-Grade 4
3.218300E-02
Grade 3-vs-Grade 4
7.921600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.906000E-01
Normal-vs-NonDiabetic
4.123000E-01
Diabetic-vs-NonDiabetic
7.491400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.314040E-01
Normal-vs-NoPancreatitis
3.770600E-01
Pancreatitis-vs-NoPancreatitis
7.341400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.339800E-01
Normal-vs-N1
2.771800E-01
N0-vs-N1
2.911000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.140400E-01
Normal-vs-TP53-NonMutant
5.383400E-01
TP53-Mutant-vs-TP53-NonMutant
9.760700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
